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TUMOR LOCATION FROM LYMPHOSCINTIGRAPHIC
MAPPING IN DETECTING AXILLARY SENTINEL LYMPH
NODE STATUS IN BREAST CANCER: EXPERIENCE
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Sentinel lymph node (SLN) biopsy is an alternative to axillary node dissection for staging breast cancer treatment.
In this article, we investigated nodal drainage patterns and tumor location using lymphoscintigraphy to
predict the axillary sentinel lymph node status. We enrolled 88 patients with clinically suspicious or biopsy-
proven breast cancer from March 2001 to October 2002. The average age of subjects was 48 ± 4 years
and the clinical stage was T1–2N0Mx. Tc-99m sulfur colloid was used in a hybrid combination of subdermal
and perilesional injections around the selected corners of the tumor or biopsy site. Sentinel lymphoscintigraphy
was performed 16–20 hours before surgery. Sentinel nodes were marked on the skin. An intraoperative gamma
probe was used to confirm the sentinel lymph node location before biopsy. Most primary tumors were in
the outer upper quadrant (52.3%), followed by the inner upper quadrant (17.0%), outer inferior quadrant
(12.5%), central areolar area (11.4%), and inner inferior quadrant (6.8%). The nodal drainage patterns on
2-hour lymphoscintigraphy were as follows: axillary alone (76.1%), internal mammary nodes alone (1.1%),
both axillary and internal mammary nodes (11.4%), and no drainage (11.4%). Internal mammary lymphatic
drainage is related to tumor location in the inner quadrants of the breast. About 11.4% of all patients had
poorly identified SLNs on lymphoscintigraphy within a 2-hour period, but there was improvement in the
overall detection rate up to 95% by intraoperative gamma probe the next day. Preoperative lymphoscintigraphic
mapping has value in providing individual lymphatic drainage patterns and tumor location that are
important in the interpretation of the results of SLN biopsy during surgery.
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Axillary lymph node dissection (ALND) in breast malig-
nancy is primarily a staging procedure, required to
determine the prognosis and select appropriate adjuvant
therapies. Sentinel lymph node (SLN) biopsy appears to
offer an alternative to routine ALND for staging in early
breast cancer [1]. Two major methods of identifying the
sentinel node have been reported, either vital blue with
direct vision at surgery or preoperative Tc-99m (99mTc)-
tagged colloidal particle lymphoscintigraphic mapping
with intraoperative detection by gamma probe [2,3]. The
preoperative lymphoscintigraphic image is used as a map
to guide the direction of lymphatic drainage from the tumor
site and localize the sentinel node from the secondary
lymph nodes [4]. The imaging information gives the surgeon
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a tailored incision plan before intraoperative detection with
the gamma probe.
Taiwan has experienced rapid growth in the incidence
of breast cancer: fivefold over the last two decades with a
concomitant threefold increase in mortality. The diagnosis
of early breast cancer had risen from 40% in 1980 to 60% in
the late 1990s. The age at breast cancer diagnosis in Taiwan
is lower than in Western populations [5].
In this study, we focused on Taiwanese patients with
breast cancer to assess the value of axillary sentinel node
prediction using lymphoscintigraphy.
PATIENTS AND METHODS
Patient selection
During a 21-month period, from March 2001 to October
2002, 87 females and one male, aged 31 to 76 years (mean,
48 years), scheduled to undergo curative surgery in our
hospital were enrolled in the study. The clinical stage of
patients was T1–2N0Mx. The average primary tumor size,
measured by ultrasonography, was 2.7 ±  1.2 cm (range,
1.5–5.0 cm). The tumor was located in one of five sections
of the breast (four quadrants and the areola). An areolar
location refers to the areola and its border. Twenty-three
cases, 26.1% of enrolled patients, had undergone excision
biopsy 1–2 weeks previously in other hospitals and were
diagnosed with malignant tumors. The remaining patients
were diagnosed as having malignant tumors from cytology
or a strong clinical suspicion.
Lymphoscintigraphy
All patients underwent preoperative sentinel lymphoscin-
tigraphy 16 or 20 hours before surgery. A standard dose of
0.4–0.6 mCi 99mTc-labeled sulfur colloid without filtration
(Syncor, Taiwan) in 1.0–2.0 mL of saline was injected in two
to four selected corners of the tumor or in the area adjacent
to the biopsy site in a hybrid combination of subdermal
and perilesional injections. The corners were selected
from palpation and previous ultrasonography. Immediate
dynamic images (E.CAM, LEHR collimator, Siemens, IL,
USA) were acquired using established techniques of grade
shield enhancement and simultaneous vertical angle dual-
head images. Dual-head images were obtained 30 minutes
to 1 hour later for image protocol. A 2-hour delayed image
was needed in some cases, where nodal uptake was poorly
identified. Certain imaging process techniques, such as
summation of dynamic images, were helpful in identifying
tiny and hypofunctional sentinel nodes. Finally, we marked
the location of sentinel nodes on the skin of the breast using
a point source matched technique and provided the surgeon
with a map of the lymphatic drainage basin for intraoperative
gamma probe guidance the next day.
Intraoperative gamma probe detection
Surgeons detected the sentinel nodes based on the previous
skin marker indication using a sterile-packed gamma probe
(neo2000TM, Neoprobe Corp, Dublin, OH, USA). Radioactive
or hot nodes were removed first in patients who had already
undergone tumor biopsy. In patients with a cytologic
diagnosis or clinical suspicion of malignancy, both primary
tumor excision and sentinel node biopsy were performed at
the same time. A count below 10% of the most radioactive
lymph nodes was regarded as background radiation.
Routine ALND including levels I–II was performed to
avoid missing “skip” metastases after definite results of
intraoperative frozen section histopathology in all patients.
Biopsy specimens from sentinel and axillary lymph
nodes, half sectioned and stained with hematoxylin and
eosin, were assessed by pathologists.
RESULTS
Tumor location
The most common tumor location was the outer upper
quadrant (OUQ; Figure 1), as in previous studies. The least
common location was the inner inferior quadrant (IIQ;
6.8%) Breast malignancies occurred about twice as often
in the right breast as in the left in this study.
Lymphoscintigraphy
After the subdermal injection of the tracer at selected corners
of the tumor, the pattern of lymphatic drainage and sentinel
node uptake depends on tumor location. Most sentinel
nodes drained into the axillary basin alone (76.1%), while
only one drained into the internal mammary basin alone
(Figure 2). The most common sentinel node distribution
was in the low axilla of the axillary lymphatic basin,
especially in patients with OUQ tumors. Of all tumors,
87.5% had SLNs in the axilla. Both axillary and internal
mammary node activity was seen in 11.4% of tumors.
However, sentinel node activity was poorly identified on 2-
hour lymphoscintigraphy in 11.4% of patients, probably
because of the short imaging time.
Figure 3 summarizes the relationship between tumor
location and the direction of lymphatic drainage on lym-
phoscintigraphy. Tumors in the outer parts of the breast
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mainly had axillary sentinel node distribution (82.4% in the
OUQ and 87.5% in the outer inferior quadrant [OIQ] in the
right breast; 66.9% in the OUQ and 100% in the OIQ in the
left breast). There was also a high percentage of axillary
sentinel node distribution in areolar tumors. Tumors in the
inner part of the breast were more likely to have both
axillary and internal mammary drainage. Figure 4 shows
an example of axillary and internal mammary lymphatic
drainage. Axillary SLN detection improved up to 95.5%
using the intraoperative gamma probe 16–18 hours after 2-
hour lymphoscintigraphy.
Pathology
From histology, the most common breast tumors in our
patients were infiltrating ductal carcinomas, accounting for
about 65% in the final diagnosis; intraductal carcinoma and
medullar carcinoma were also found. The negative predictive
rate of SLN biopsy in our cases was about 10%.
Figure 1. Tumor location in
the four breast quadrants and
areola. OUQ = outer upper
quadrant; OIQ = outer in-
ferior quadrant; IIQ = inner
inferior quadrant; IUQ =
inner upper quadrant.
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Figure 2. Sentinel lymph
node distribution in the axil-
lary and internal mammary
basins or both.
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Figure 3. Analysis of sentinel lymph node distribution in the four breast quadrants and areola shows a relatively high probability of internal
mammary lymphatic drainage basin for tumors in inner quadrants. OUQ = outer upper quadrant; OIQ = outer inferior quadrant; IIQ = inner inferior
quadrant; IUQ = inner upper quadrant; A = axillary drainage; I = internal mammary drainage; A   I = axillary and internal mammary drainage;
PD = poorly identified sentinel nodes.
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DISCUSSION
Cabanas first described the value of SLNs in his studies of
patients with penile cancer in 1977 [6]. SLNs are considered
the first afferent nodes for lymphatic drainage from the
tumor site to the adjacent lymphatic basin. Accurate location
and biopsy of sentinel nodes will predict regional nodal
status. Krag et al originally reported location of the sentinel
node in 82% of 22 patients, with 100% accuracy in predicting
axillary node status using intraoperative gamma probe
detection of previously injected 99mTc sulfur colloid in breast
cancer [7]. In this study, we used radiotracer tagging sulfur
colloid to identify the sentinel nodes and determine the
relationship between tumor location and regional sentinel
node drainage by lymphoscintigraphy. After accurate
location and biopsy of sentinel nodes, regional axillary
node status can be predicted and compared with the result
of traditional ALND.
Many factors, including technical issues of lympho-
scintigraphic mapping and probe detection, will result
in variations in the accuracy of SLN detection. Alazraki et al
concluded that the major technical variables are the radio-
pharmaceutical used, the injection site, volume, activity,
and the use of the imaging result [4,8]. From our experience,
we agree that small-particle radiopharmaceuticals, such as
phytate, allows easy detection of SLNs in breast cancer [9].
We had a similar result using phytate and sulfur colloid for
sentinel node detection in the same patient (Figure 4).
Smaller particles facilitate rapid transfer into the lymphatic
system, yet are only retained in SLNs for several hours.
Larger colloid particles show a much slower rate of clearance
from the interstitial space and are likely to show a slower
accumulation in SLNs [2,4,8]. Sufficiently large particles do
not seem to leak from SLNs. Therefore, we used variable-
sized unfiltered large sulfur colloid particles with similar
representation of tumor spread within the local lymphatic
drainage around the breast tumor, especially in our 2-day
protocol. With unfiltered sulfur colloid, adequate radio-
tracer volume and activity are necessary to reveal the true
distribution of regional lymphatic drainage and enhance
detection of SLNs on lymphoscintigraphy [4]. Although the
intraoperative gamma probe has high sensitivity in detecting
SLNs, preoperative lymphoscintigraphy still has a role to
play in identifying regionally functional lymphatic anatomy
in breast cancer. It not only provides the planning map for
the surgeon, but also serves as an imaging record. In this
study, we used a grade-shield and simultaneous vertical
angle imaging technique to enhance sentinel node detection
[10]. Using unfiltered sulfur colloid and established imaging
techniques, SLN detection reached 87% on lymphoscinti-
graphy within a 2-hour period and improved up to 95%
with intraoperative gamma probe after a 16- to 18-hour
period.
The status of lymph vessels around the breast lump and
individual variations are also major factors resulting in
variable regional lymphodynamic patterns and the final
detection of SLNs on lymphoscintigraphy. The rates of
lymph flow within lymphatic collecting vessels vary in
different cutaneous parts of the body, the most rapid flow
occurring in the leg and foot (10.2 cm/min) and slower flow
in the head and neck (1.5 cm/min) [11]. The lymphatic flow
rate in the cutaneous part of the anterior trunk is about 2.8
cm/min. The lymphatic vessels have an intrinsic pump
mechanism maintaining steady lymph flow [12], but this
mechanism responds to an increase in hydrostatic pres-
sure by significantly increasing lymph flow. Local heat,
inflammation, and external massage will increase lymph
flow [13]. Because of its embryologic origin in the ectoderm,
the mammary gland is, in a sense, an organ of the skin [2,14].
Therefore, lymphatic drainage in the breast closely parallels
lymph flow in the overlying skin [2,14]. After subdermal
injection at the corners of the lump, sentinel nodes could not
be identified in 11.4% of our cases on 2-hour lymphoscinti-
graphy. Of patients with poorly identified sentinel nodes,
two had undergone recent biopsy, the average tumor size
was 2 cm, and the ratio of inner to outer tumor location was
4:5. Only two patients were older than 65 years and the
other patients were younger than the overall average (48
Figure 4. A young female with a breast lump in the inner inferior
quadrant received injection of Tc-99m-labeled sulfur colloid (left) and
phytate (right) consecutively using a hybrid injection technique. Afferent
lymphatic drainage from the lump into both axillary and internal
mammary lymph basins was noted in the first sulfur colloid image. After
injection of the smaller particle, phytate, greater nodal uptake in the
lymphatic basins was revealed.
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years). This suggests that tumor location in the inner part of
the breast is a factor causing delayed lymphatic drainage
into axillary SLNs. Age and tumor size were not significantly
related to poor identification of sentinel nodes in this study.
However, we believe that lymphatic flow is relatively
delayed in older patients and probably in those with larger
tumors. Borgstein et al reported significant correlation
between mapping success and invasive tumor size of less
than 5 cm [1]. However, other investigators found no
correlation [15,16]. Prior breast surgery with scar formation
may alter the original lymph drainage and lead to detection
failure or even false-negative sentinel nodes [14]. We agree
that scarring will disturb the lymphatic drainage, but this
does not include recent biopsy.
In this study, the most common location of breast tumors
was the OUQ (52.3%); tumors around the areola constituted
about 11% of cases, while those in the IIQ constituted only
6.8%. This was very similar to previously reported dis-
tributions: 52% in the OUQ, 14% in the inner upper quadrant,
6% in the IIQ, 16% in the OIQ, and 12% in the central areola
area [14]. The distribution of lymphatic drainage from the
breast was approximately proportional to the three routes
of blood supply: most of the lymph drains to the axillary
lymph nodes, about 3% drains to the parasternal internal
mammary chain nodes while, under normal circumstances,
the posterior intercostal lymph nodes receive small pro-
portions of lymph flow from the breast [2]. Overall, 87.5%
of patients in this study had axillary lymphatic drainage,
but internal lymphatic drainage alone was rare (Figure 2).
Tumors in the outer quadrant of the breast, including those
in the areolar area, always drained into the axillary lymphatic
system, while those in the inner quadrant had a higher ratio
of internal mammary drainage (Figure 3). Dupont et al
found 2.4% of cases with internal mammary nodes using
the gamma probe, and 73% of these were associated with
inner quadrant lesions [16].
Some authors suggest that subareolar injection is an
extremely accurate and cost-effective method of sentinel
node identification in breast cancer [17]. We prefer a hybrid
combination of subdermal and peritumoral injections
around the corners of the tumor, especially in the inner part
of the breast, because the chance of internal mammary node
visualization is increased when the primary tumor is located
medially [18].
Generally speaking, there is a concordant result of
pathology between SLNs and axillary lymph nodes.
However, the approximately 10% false negative rate with
sentinel nodes in this study was similar to those from
previous reports [19–21]. The fact that one-third of patients
with positive SLN metastasis had a negative result on
traditional axillary node biopsy demonstrates the great
value of sentinel nodal biopsy for nodal staging of tumors.
In conclusion, SLNs in the low axilla are identified in
most breast cancer patients in Taiwan. Several factors,
such as age, scarring and tumor status, will interfere with
the dynamic pattern of local lymphatic flow in the breast.
Lymphoscintigraphic mapping provides individual lym-
phatic drainage patterns in addition to tumor location,
which is important in the interpretation of the results of
SLN biopsy.
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